Cornerstone Capital’s Viking Therapeutics VKTX Stock Holding History

Cornerstone Capital’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.83M	Buy	86,900 +64,350	+285%	+$2.07M	0.28%	47
2025 Q4	$793K	Hold	22,550	–	–	0.08%	69
2025 Q3	$593K	Sell	22,550 -1,730	-7%	-$51.6K	0.06%	71
2025 Q2	$643K	Hold	24,280	–	–	0.07%	66
2025 Q1	$586K	Sell	24,280 -520	-2%	-$16.4K	0.06%	69
2024 Q4	$998K	Sell	24,800 -4,970	-17%	-$283K	0.11%	62
2024 Q3	$1.88M	Sell	29,770 -4,180	-12%	-$245K	0.18%	56
2024 Q2	$1.8M	Hold	33,950	–	–	0.18%	53
2024 Q1	$2.78M	Sell	33,950 -76,025	-69%	-$3.38M	0.29%	50
2023 Q4	$2.05M	Sell	109,975 -170	-0.2%	-$2.22K	0.22%	48
2023 Q3	$1.22M	Hold	110,145	–	–	0.15%	53
2023 Q2	$1.79M	Sell	110,145 -44,510	-29%	-$933K	0.21%	48
2023 Q1	$2.58M	Buy	154,655 +15,300	+11%	+$158K	0.31%	48
2022 Q4	$1.31M	Sell	139,355 -4,625	-3%	-$20.6K	0.17%	50
2022 Q3	$392K	Buy	143,980 +4,840	+3%	+$15.9K	0.06%	68
2022 Q2	$402K	Buy	139,140 +4,095	+3%	+$10.1K	0.05%	69
2022 Q1	$405K	Buy	135,045 +12,825	+10%	+$46K	0.05%	69
2021 Q4	$562K	Hold	122,220	–	–	0.06%	66
2021 Q3	$768K	Sell	122,220 -12,400	-9%	-$76.6K	0.09%	63
2021 Q2	$806K	Buy	134,620 +975	+0.7%	+$5.79K	0.09%	61
2021 Q1	$845K	Buy	133,645 +5,180	+4%	+$36.4K	0.1%	60
2020 Q4	$723K	Buy	128,465 +3,000	+2%	+$18.2K	0.09%	57
2020 Q3	$730K	Buy	125,465 +10,852	+9%	+$74.7K	0.11%	48
2020 Q2	$826K	Buy	114,613 +2,838	+3%	+$18.8K	0.14%	43
2020 Q1	$523K	Sell	111,775 -134,021	-55%	-$824K	0.11%	46
2019 Q4	$1.97M	Sell	245,796 -2,329	-0.9%	-$17K	0.28%	46
2019 Q3	$1.71M	Sell	248,125 -1,000	-0.4%	-$7.43K	0.27%	44
2019 Q2	$2.07M	Buy	249,125 +4,325	+2%	+$37K	0.32%	44
2019 Q1	$2.43M	Buy	244,800 +32,200	+15%	+$270K	0.4%	41
2018 Q4	$1.63M	Buy	212,600 +32,479	+18%	+$388K	0.29%	49
2018 Q3	$3.14M	Buy	180,121 +34,621	+24%	+$412K	0.48%	41
2018 Q2	$1.38M	Buy	145,500 +58,850	+68%	+$391K	0.23%	45
2018 Q1	$379K	Hold	86,650	–	–	0.06%	66
2017 Q4	$352K	Buy	+86,650	New	+$252K	0.06%	69